← FDA Drug Approvals (Drugs@FDA)

AMPICILLIN AND SULBACTAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACS DOBFAR · Approved 2009-12-23

Drug application

FDA Application #

ANDA065403

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMPICILLIN AND SULBACTAM

Generic name

AMPICILLIN AND SULBACTAM

Active ingredients

AMPICILLIN SODIUM; SULBACTAM SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

ACS DOBFAR

Manufacturer

Sagent Pharmaceuticals

First approval

2009-12-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown